MED POLONIA SP Z O O, Clinical Trials Department,Poznan

Poznan 60693

0 studies enrolling now · 4 studies all time

What they study most

Lung Cancer, Non-squamous, Non-small Cell, Neoplasms, Non-squamous, Non-Small-Cell Lung Cancer, Small Cell Lung Carcinoma (SCLC)

Studies at this site

• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer — Running, not enrolling
• This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) — Completed
• A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours — Completed